RecruitingNCT03296202
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV: The ANRS CO3 Aquitaine Cohort - AquiVIH-NA
Sponsor
University Hospital, Bordeaux
Enrollment
7,200 participants
Start Date
Jul 18, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
HIV infection is now a chronic disease in countries where antiretroviral treatments (ART) are largely available. Long-term follow-up is required to describe and understand the evolution of morbidities and complications as well as new treatments side effects. The main objective of the cohort is to describe and study the evolution of HIV infection in ART-treated individuals.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patients aged over 18 years old.
- Confirmed HIV infection
- Signed informed consent
Exclusion Criteria1
- HIV-2 infection
Locations(24)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03296202
Related Trials
A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa
NCT053737583 locations
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
NCT0720254662 locations
First Time in Human Study of Long Acting VH4524184 Formulations
NCT063105512 locations
Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People
NCT058160831 location
A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
NCT0669480589 locations